Artemisone effective against murine cerebral malaria
Open Access
- 9 August 2010
- journal article
- Published by Springer Science and Business Media LLC in Malaria Journal
- Vol. 9 (1), 227
- https://doi.org/10.1186/1475-2875-9-227
Abstract
Background: Artemisinins are the newest class of drug approved for malaria treatment. Due to their unique mechanism of action, rapid effect on Plasmodium, and high efficacy in vivo, artemisinins have become essential components of malaria treatment. Administration of artemisinin derivatives in combination with other anti-plasmodials has become the first-line treatment for uncomplicated falciparum malaria. However, their efficiency in cases of cerebral malaria (CM) remains to be determined.Methods: The efficacy of several artemisinin derivatives for treatment of experimental CM was evaluated in ICR or C57BL/6 mice infected byPlasmodium bergheiANKA. Both mouse strains serve as murine models for CM.Results: Artemisone was the most efficient drug tested, and could prevent death even when administered at relatively late stages of cerebral pathogenesis. No parasite resistance to artemisone was detected in recrudescence. Co-administration of artemisone together with chloroquine was more effective than monotherapy with either drug, and led to complete cure. Artemiside was even more effective than artemisone, but this substance has yet to be submitted to preclinical toxicological evaluation.Conclusions: Altogether, the results support the use of artemisone for combined therapy of CM.Keywords
This publication has 67 references indexed in Scilit:
- Artemisinin Resistance inPlasmodium falciparumMalariaThe New England Journal of Medicine, 2009
- Artemisinin-based combination therapy for treating uncomplicated malariaCochrane Database of Systematic Reviews, 2009
- Probing the multifactorial basis of Plasmodium falciparum quinine resistance: Evidence for a strain-specific contribution of the sodium-proton exchanger PfNHEMolecular and Biochemical Parasitology, 2009
- Characterization of cerebral malaria in the outbred Swiss Webster mouse infected by Plasmodium berghei ANKAInternational Journal of Experimental Pathology, 2009
- Sub-microscopic infections and long-term recrudescence of Plasmodium falciparum in Mozambican pregnant womenMalaria Journal, 2009
- First Assessment in Humans of the Safety, Tolerability, Pharmacokinetics, and Ex Vivo Pharmacodynamic Antimalarial Activity of the New Artemisinin Derivative ArtemisoneAntimicrobial Agents and Chemotherapy, 2008
- Qinghaosu (Artemisinin): The Price of SuccessScience, 2008
- The Fe2+‐Mediated Decomposition, PfATP6 Binding, and Antimalarial Activities of Artemisone and Other Artemisinins: The Unlikelihood of C‐Centered Radicals as Bioactive IntermediatesChemMedChem, 2007
- Investigation of the immunosuppressive activity of artemether on T‐cell activation and proliferationBritish Journal of Pharmacology, 2007
- Artemisinins target the SERCA of Plasmodium falciparumNature, 2003